# Spravato

NDC: 50458-028
Generic name: Esketamine Hydrochloride
Labeler / Manufacturer: Janssen Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: NASAL
Marketing started: 20190305

FDA application: NDA211243

## Active ingredients

- ESKETAMINE HYDROCHLORIDE: 28 mg/.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50458-028"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50458-028
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed